The Quickening Pace of Oncology Research

Author:
Rodger J. Winn
Search for other papers by Rodger J. Winn in
Current site
Google Scholar
PubMed
Close
 MD
Full access

Rodger J. Winn is the Editor-in-Chief of JNCCN. His past positions include Associate Professor of Clinical Medicine at the University of Texas M. D. Anderson Cancer Center. Dr. Winn received his medical degree from Jefferson Medical College of Philadelphia. His postgraduate training includes an internship and residency at Jefferson Medical College, and he also completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. He is board certified in internal medicine and holds subspecialty certification in oncology.

  • Collapse
  • Expand
  • 1

    Singhal S, Mehta J, Desikan R et al.. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999;341:1565-1571.

  • 2

    Richardson PG, Barlogie B, Bertenson J et al.. A Phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003;348:2609-2617.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 117 70 5
PDF Downloads 46 10 0
EPUB Downloads 0 0 0